[1]Chemicalandpharmaceuticalbulletin,1987,vol.35,p.1991-1997
[2]Patent:WO2021/41721,2021,A1.Locationinpatent:Paragraph0078
Title: The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany) 20040719
Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
